Login / Signup

Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis.

Dominic BettingerEleni GkikaMichael SchultheissNicolas GlaserSophie LangeLars MaruschkeNico BuettnerSimon KirsteUrsula NestleAnca-Ligia GrosuRobert ThimmeThomas B Brunner
Published in: BMC cancer (2018)
SBRT after prior HCC therapy in selected patients shows comparable LC at 1 year, OS and 1-year mortality compared to patients treated with TACE.
Keyphrases
  • radiation therapy
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • cardiovascular events
  • type diabetes
  • risk factors
  • data analysis